EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Antibiotic resistance profile of Helicobacter pylori to 14 antibiotics: a multicenter study in Fujian, China

Xueping Huang iD, Baihe Wu, Qiuzhao Chen, Yushan Chen, Xinhua Ji, Xiang Zhou, Biao Suo, Zhihui Lin, Xiaoling Zheng

PeerJ · 2023

DOI: 10.7717/peerj.15611 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PeerJ, 2023. Verfasst von Xueping Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Medical Innovation Project of Fujian Provincial Health Commission, Zhuhai Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aim Efficacy of Helicobacter pylori (H . pylori ) eradication is related to the local antimicrobial resistance epidemiology. We aimed to investigate the antibiotic resistance of H. pylori in Fujian, China.

Methods

H. pylori -infected patients in four centers were enrolled in the study from Oct 2019 to Jan 2022. The bacteria were isolated, cultured and identified from the biopsy of patients’ gastric mucosa samples. Antimicrobial susceptibility testing was performed by a modified broth microdilution method for H. pylori to seven guideline-recommended antibiotics and seven potential choices for H. pylori eradication.

Results

A total of 205 H. pylori strains were isolated. The resistance rates of amoxicillin (AMX), amoxicillin and clavulanate potassium (AMC), cefixime (CFM), gentamicin (GEN), tetracycline (TET), doxycycline (DOX), azithromycin (AZM), clarithromycin (CLR), levofloxacin (LVFX), sparfloxacin (SPFX), metronidazole (MTZ), tinidazole (TID), rifampicin (RFP) and furazolidone (FZD) were 11.22%, 12.20%, 7.32%, 12.20%, 4.88%, 4.39%, 44.39%, 43.90%, 30.24%, 21.46%, 40.98%, 45.85%, 5.37% and 10.24%, respectively. The rates of pan-sensitivity, single, double, triple and multiple resistance for seven guideline-recommended antibiotics were 32.68%, 30.24%, 13.17%, 7.76%, and 14.15%, respectively. The main double-resistance patterns were CLR+MTZ (10/205, 5%) and CLR+LVFX (9/205, 4%). The main triple-resistance pattern was CLR+MTZ+ LVFX (15/205, 7%).

Conclusions

In Fujian, the prevalence of H. pylori resistance to AZM, CLR, LVFX, SPFX, MTZ, and TID was high, whereas that to AMX, AMC, GEN, CFM, TET, DOX, RFP and FZD was relatively low. CFM and DOX are promising new choices for H. pylori eradication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsHumansAnti-Bacterial AgentsMicrobial Sensitivity TestsMetronidazoleClarithromycinAmoxicillinTetracyclineDrug Resistance, BacterialFurazolidoneCefiximeDoxycyclineLevofloxacin

Stichwörter der Autor:innen

Antibiotic resistanceChinaFujianHelicobacter pyloriMulticenter study

Substanzen

Anti-Bacterial AgentsMetronidazoleClarithromycinAmoxicillinTetracyclineFurazolidoneCefiximeDoxycyclineLevofloxacin

Autor:innen und Institutionen

  • Department of Gastroenterology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Gastroenterology, Fujian Provincial Hospital, Fuzhou, Fujian, China.
  • Department of Gastroenterology, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China.
  • Department of Gastroenterology, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
  • Department of Gastroenterology, Fuzhou No.1 Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Gastroenterology, Pucheng Hospital, Nanping, Fujian, China.

ORCID-Profile: Xueping Huang

Förderung

  • Natural Science Foundation of Fujian Province
  • Medical Innovation Project of Fujian Provincial Health Commission
  • Zhuhai Science and Technology Project
  • Startup Fund for Scientific Research of Fujian Medical University

Zitieren

APA

Huang, X., Wu, B., Chen, Q., Chen, Y., Ji, X., Zhou, X., Suo, B., Lin, Z., & Zheng, X. (2023). Antibiotic resistance profile of Helicobacter pylori to 14 antibiotics: a multicenter study in Fujian, China. PeerJ. https://doi.org/10.7717/peerj.15611

Vancouver

Huang X, Wu B, Chen Q, Chen Y, Ji X, Zhou X, et al. Antibiotic resistance profile of Helicobacter pylori to 14 antibiotics: a multicenter study in Fujian, China. PeerJ. 2023. doi:10.7717/peerj.15611

BibTeX
@article{Huang2023,
  author = {Huang, Xueping and Wu, Baihe and Chen, Qiuzhao and Chen, Yushan and Ji, Xinhua and Zhou, Xiang and Suo, Biao and Lin, Zhihui and Zheng, Xiaoling},
  title = {Antibiotic resistance profile of Helicobacter pylori to 14 antibiotics: a multicenter study in Fujian, China},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.15611}
}
Kostenlos starten →